Serological evidence of human granulocytic ehrlichiosis in Switzerland

Nicola Pusterla, R. Weber, C. Wolfensberger, G. Schär, R. Zbinden, W. Fierz, John E Madigan, J. S. Dumler, H. Lutz

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections, those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.

Original languageEnglish (US)
Pages (from-to)207-209
Number of pages3
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume17
Issue number3
StatePublished - 1998

Keywords

  • Human granulocytic ehrlichiosis
  • Indirect immunofluorescent antibody test
  • Prevalence
  • Switzerland

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Fingerprint Dive into the research topics of 'Serological evidence of human granulocytic ehrlichiosis in Switzerland'. Together they form a unique fingerprint.

  • Cite this

    Pusterla, N., Weber, R., Wolfensberger, C., Schär, G., Zbinden, R., Fierz, W., Madigan, J. E., Dumler, J. S., & Lutz, H. (1998). Serological evidence of human granulocytic ehrlichiosis in Switzerland. European Journal of Clinical Microbiology and Infectious Diseases, 17(3), 207-209.